Iovance Biotherapeutics, Inc. (IOVA)

NASDAQ: IOVA · IEX Real-Time Price · USD

11.71

-0.15 (-1.26%)

At close: Apr 24, 2024, 4:00 PM

11.92

+0.21 (1.79%)

After-hours: Apr 24, 2024, 7:52 PM EDT

Iovance Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2007
Cash & Equivalents	181.32	238.16	84.31	72.85	19.42	82.15	145.37	106.72	33.59	44.91	Upgrade
Short-Term Investments	164.98	240.11	426.18	562.11	293.11	386.37	0	59.75	70.11	0	Upgrade
Cash & Cash Equivalents	346.3	478.28	510.49	634.96	312.53	468.52	145.37	166.47	103.7	44.91	Upgrade
Cash Growth	-27.59%	-6.31%	-19.60%	103.17%	-33.29%	222.29%	-12.67%	60.53%	130.91%	128.29%	Upgrade
Receivables	0.15	0	0	0	0	0	0	0	0	0	Upgrade
Inventory	10.37	0	0	0	0	0	0	0	0	0	Upgrade
Other Current Assets	-48.97	0.84	-2.54	1.14	3.96	6.85	3.92	3.04	0.28	0.07	Upgrade
Total Current Assets	307.85	479.12	507.96	636.1	316.49	475.37	149.29	169.51	103.98	44.98	Upgrade
Property, Plant & Equipment	176.55	178.25	169.92	113.92	19.23	2.68	2.45	2.37	1.68	1.53	Upgrade
Long-Term Investments	0	0	91.59	0	0	0	0	0	0	0	Upgrade
Goodwill and Intangibles	229.26	0	0	0	0	0	0	0	0	0	Upgrade
Other Long-Term Assets	66.7	6.62	7.87	18.44	8.93	2.76	3.63	0	0	0	Upgrade
Total Long-Term Assets	472.5	184.87	269.38	132.36	28.16	5.45	6.08	2.37	1.68	1.53	Upgrade
Total Assets	780.35	663.98	777.33	768.46	344.66	480.82	155.37	171.89	105.65	46.51	Upgrade
Accounts Payable	33.12	26.6	27.38	13.51	15.57	2.74	1.23	0.86	0.96	1.33	Upgrade
Current Debt	7.78	12.59	5.06	6.28	7.25	0	0	0	0	0	Upgrade
Other Current Liabilities	69.41	52.3	56.77	35.07	16.27	11.66	8.36	4.11	0.67	0.33	Upgrade
Total Current Liabilities	110.31	91.49	89.2	54.87	39.08	14.4	9.6	4.97	1.63	1.66	Upgrade
Long-Term Debt	68.09	72.86	66.47	45.38	4.25	0	0	0	0	0	Upgrade
Other Long-Term Liabilities	17.35	0	0	11.71	2.35	0.23	0.3	0	0	0	Upgrade
Total Long-Term Liabilities	85.43	72.86	66.47	57.09	6.6	0.23	0.3	0	0	0	Upgrade
Total Liabilities	195.74	164.34	155.67	111.96	45.68	14.63	9.89	4.97	1.63	1.66	Upgrade
Total Debt	75.86	85.45	71.53	51.66	11.5	0	0	0	0	0	Upgrade
Debt Growth	-11.22%	19.45%	38.47%	349.21%	-	-	-	-	-	-	Upgrade
Retained Earnings	-2,012.38	-1,568.34	-1,172.45	-830.19	-570.61	-372.76	-249.18	-157.12	-104.22	-76.56	Upgrade
Comprehensive Income	2.53	-0.9	-0.6	0.02	0.22	-0.04	0	0.03	0.05	0	Upgrade
Shareholders' Equity	584.61	499.64	621.66	656.5	298.97	466.19	145.48	166.92	104.02	44.85	Upgrade
Net Cash / Debt	270.44	392.83	438.96	583.3	301.03	468.52	145.37	166.47	103.7	44.91	Upgrade
Net Cash / Debt Growth	-31.16%	-10.51%	-24.75%	93.77%	-35.75%	222.29%	-12.67%	60.53%	130.91%	128.29%	Upgrade
Net Cash Per Share	1.15	2.47	2.86	4.22	2.42	4.82	2.23	3.01	2.34	1.80	Upgrade
Working Capital	197.54	387.63	418.76	581.23	277.41	460.98	139.7	164.54	102.35	43.31	Upgrade
Book Value Per Share	2.49	3.14	4.05	4.75	2.40	4.79	2.23	3.02	2.34	1.79	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).